Profound: Phase III Study of the Efficacy and Safety of Olaparib versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Homologous Recombination Repair Gene (HRR) Alterations

Affiliation auteurs!!!! Error affiliation !!!!
TitreProfound: Phase III Study of the Efficacy and Safety of Olaparib versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Homologous Recombination Repair Gene (HRR) Alterations
Type de publicationJournal Article
Year of Publication2020
AuteursFeyerabend S., Hussain M., Mateo J., Fizazi K., Saad F., Shore N., Sandhu S., Chi K., Sartor O., Agarwal N., Olmos D., Thiery-Vuillemin A., Twardowski P., Mehra N., Goessl C., Kang J., Burgents J., Wu W., Kohlmann A., Adelman C., de Bono J.
JournalONCOLOGY RESEARCH AND TREATMENT
Volume43
Pagination71-72
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN2296-5270